Our study provides the first evidence that SKAP55 or ADAP deficiency greatly enhances CD8+ CTL cytotoxicity for tumor prevention or therapy by reducing PD-1 expression (see model in Supplementary Fig S7). Here, SKAP1 is linked to neoplasm.